Oxygenta Pharmaceutical Limited documents

Explore the latest documents from Oxygenta Pharmaceutical Limited, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Description

Event date

Documents and forms

2026

Q1 25/26

Aug 20, 2025

Interim report

2025

Q4 24/25

May 30, 2025

Interim report

Q3 24/25

Feb 14, 2025

Interim report

Q2 24/25

Nov 14, 2024

Interim report

Q1 24/25

Aug 14, 2024

Interim report

2024

Q4 23/24

May 30, 2024

Interim report

Q3 23/24

Feb 14, 2024

Interim report

Q2 23/24

Nov 14, 2023

Interim report

Q1 23/24

Aug 14, 2023

Interim report